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GEORGE 1. KLEIN, MD, FACC
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Invasive electrophysiologic testing and noninvasive test-
ing were compared as methods for identifying patients
with Wolff-Parkinson-White syndrome at risk for sud-
den death. Sixty-seven patients were studied, including
nine with a history of ventricular fibrillation. Electro-
physiologic testing, using the shortest interval between
consecutivepre-excited beats (shortest RR interval) ~250
ms during induced atrial fibrillation to define risk , iden-
tified seven of nine patients with previous ventricular
fibrillation. The sensitivity increased to 87.5% if one
patient with prior amiodarone therapy was excluded.
Electrophysiologic testing had a specificity of 48.3 % and
a low predictive accuracy (18.9%) when using the short-
est RR interval ( ~250 ms) to identify the risk for sudden
death.
Continuous pre-excitation after disopyramide (2 mg/kg
body weight, intravenously) had it sensitivity of 71.4%,
specificity of 26.1 % and predictive accuracy of 12.8%
A number of methods have been used to identify patients
with Wolff-Parkinson-White syndrome at risk for sudden
death. Block of conduction in the accessory pathway during
exercise testing (1,2) or after ajmaline (3) or procainamide
(4) infusion has been associated with long accessory path-
way effective refractory period s and, thus, has been used
to ident ify patients unlikel y to be at risk for sudden death
in the event of atrial fibrillati on . However , most previou s
studies assess ing these method s have been limited by factors
such as small patient numbers (1.5. 6), selection of patients
with either short (7) or long (5) refractory periods and the
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for identifying patients with sudden death. Continuous
pre-excitation during an exercise test identified these pa-
tients with a sensitivity of 80%, a specificity of 28.6%
and a predictive accuracy of 11.8%. These noninvasive
tests could also be used to predict the shortest RR in-
terval observed during induced atrial fibrillation. Con-
tinuous pre-excitation on both tests used in combination
had a sensitivity of 91.2%, a specificity of 66.7% and a
predictive accuracy of 75.6% for predicting the shortest
RR interval ~250 ms.
Thus, both invasive and noninvasive techniques have
a good sensitivity but a low specificity for identifying
patients with Wolff-Parkinson-White syndrome and sud-
den death. Slow ventricular rates during atrial fibril-
lation and block of accessory pathway conduction by
noninvasive methods are associated with a low risk of
sudden death .
(J Am Coil Cardiol 1987;/O:373-8l)
failure to include patients with documented cardiac arrest
(5). Moreover, Critelli et al. (8) questioned the usefulness
of noninvasive techniques that are performed during sinus
rhythm. They demonstrated examples of apparent block of
accessory pathway conduction durin g exercise and after
ajmaline adm inistration in patients capable of sustaining
atrial fibrillation with rapid ventricular respon ses. Exercise
and drug infusion would have falsely identified these pa-
tients as not being at risk for sudden death. Thus . electro-
physiologic assessment of the shortest RR interval in atrial
fibrillation has generall y been accepted as the reference stan-
dard in determining risk in the Wolff-Parkin son-White syn-
drome (9- 11). However, the sensitivity and spec ificity of
e1ectrophysiologic testing for ident ifying patients at risk for
sudden death have not been assessed , particularly in relation
to the noninvasive techniques.
To characterize the sensitivity and specific ity of each of
these investigations for identifying patients at risk for sudd en
cardiac death in the event of atrial fibrillation. we examined
the effects of exercise and disopyramide infusion on anter-
ograde pre-excitation in patient s who had also been assessed
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by electrophysiologic testing. The study group included pa-
tients with a prior cardiac arrest, and we determined the
value of each of the investigations in identifying these pa-
tients.
Methods
Study patients. Sixty-seven patients with manifest pre-
excitation on a 12 lead rest ECG participated in the study.
Patients were referred for electrophysiologic assessment of
arrhythmias related to the accessory pathway (n = 55) or
for the assessment of the risk of sudden death in asymp-
tomatic patients (n = 12). There were 49 men and 18
women with a mean age of 34.2 ± 13.4 years (range 12
to 72). Patients with ischemic heart disease or congestive
heart failure were excluded, leaving a healthy group of
patients largely capable of exercising to 90% of predicted
heart rate. Clinical indications for investigation in symp-
tomatic patients included atrioventricular (AV) reciprocat-
ing tachycardia (n = 24), atrial fibrillation (n = 19), both
reciprocating tachycardia and atrial fibrillation (n = 5),
undocumented palpitation (n = 4) and syncope (n = 3).
Study protocol. History. physical examination, chest
X-ray film and echocardiogram were performed in all pa-
tients. All studies were performed in patients after antiar-
rhythmic drugs had been withdrawn for at least 2 days. A
symptom-limited graded treadmill submaximal exercise test
was carried out using a modified Bruce protocol. The ECG
was monitored throughout the exercise test by a physician
and a 12 lead ECG tracing was run automatically every 3
minutes and manually activated when there was a change
in the ECG configuration.
Disopyramide was administered through a peripheral in-
travenous line in a dose of up to 2 mg/kg administered over
3 minutes. The ECG was monitored continuously and the
infusion was stopped if block of accessory pathway con-
duction was observed. When no change in the ECG was
produced during drug infusion, a further 10 minute obser-
vation period followed.
Electrophysiologic testing. This was carried out by a
standard method (12). All patients had catheters placed in
position to record high right atrial, His bundle, right ven-
tricular and coronary sinus electrograms. Patients with a
right-sided accessory pathway underwent mapping of the
right atrium during reciprocating tachycardia using a steer-
able catheter. The data include anterograde accessory path-
way effective refractory period and the shortest interval
between consecutive pre-excited beats during induced atrial
fibrillation (shortest RR interval). Accessory pathway ef-
fective refractory period was measured after an eight beat
drive. The data are presented for a basic drive cycle length
of 600 ms because this permitted analysis of refractoriness
in patientswith long accessory pathway effective refractory
periods. The RR intervals between pre-excited beats during
either inducedatrial fibrillation or atrial fibrillation sustained
by rapid atrial pacing (cycle length 50 to 150 ms) was
recorded for at least I minute to obtain a sample of at least
100 cycles. The shortest RR interval was determined from
this sample(13). The electrophysiologic data were recorded
on an FM tape recorder and on paper at 100 mm/s (Min-
gograf, Siemens). Measurements were made from the paper
tracings using a graphics tablet (Numonics)and a computer
(Hewlett-Packard 216),
Sensitivity. specificity and predictive accuracy of a pos-
itive test were calculated on the basis of the following def-
initions . Patients with a history of ventricular fibrillation
were considered to have a positive history and those with
no such history were considered to have a negative history.
A shortestRR interval ::;250ms at electrophysiologic testing
was considered a positive result for predicting risk for sud-
den death. Continuous pre-excitation with disopyramide or
graded treadmill exercise testing was considered a positive
result, suggesting a short accessory pathway refractory pe-
riod on the basis of previous data (1-4) . The noninvasive
testingcould alsobe used to predictthe shortestRR interval.
Because it may be desirable to be more conservative and
detect patients with a long shortest RR interval who do not
need electrophysiologic testing, we examined the use of
noninvasive testing to predict a number of different shortest
RR intervals ranging from ::;250 to ::;340 ms.
Statistics. Statistical analysis of data was performed us-
ing a one-wayanalysisof variance, unpairedStudent's t test
and paired t test when appropriate . All data are expressed
as mean ± SO.
Results
Electrophysiologic Testing
Patients with prior cardiac arrest. All 67 patients
underwent invasive electrophysiologic testing. Nine had a
documented prior episode of cardiac arrest requiring emer-
gency defibrillation. These patientswereconsidered to have
a positivehistory for the assessment of sensitivity and spec-
ificity of the investigations in identifying patients at risk for
sudden death (Fig. I). The mean shortest interval between
consecutive pre-excited complexes during atrial fibrillation
(shortest RR interval) was 214 ± 85 ms and the anterograde
accessory pathway effective refractory period was 263 ±
38 ms. Five of the nine patients had an accessory pathway
refractory period > 250 ms, suggesting that this measure
does not correlate as well with sudden death as does the
shortest RR interval. Seven of the patients had a shortest
RR interval ::;250 ms with a mean of 176 ± 33 ms. These
seven were considered to have a true positive result on
electrophysiologic testing (Table I).
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Figure 1. Spontaneous onset of ven-
tricular fibrillation during atrial fibril-
lation in a patient with Wolff-Parkin-
son-White syndrome. Theshortest RR
interval between consecutive pre-ex-
cited QRS complexes was 237 msdur-
ing a 10minute period of atrial fibril-
lation. Immediately at the onset of
ventricular fibrillation (arrow), a short
RR interval is observed, suggesting a
need for long sampling periods in some
patients. RV = right ventricular.
Table 1. Testing Results in Patients With (n 9) and Without
(n = 58) a History of Cardiac Arrest
*Includes one patient with gradual loss of pre-excitation who was
excluded from subsequent calculations. iIncludes eight patients with grad-
ual loss of pre-excitation. Shortest RR interval = shortest interval between
consecutive pre-excited beats during atrial fibrillation; VF = past history
of cardiac arrest due to ventricular fibrillation.
Two of the patients had a shortest RR interval >250 ms
in the electrophysiology laboratory (396 and 295 ms, re-
spectively) and thus had a false negatives result for assessing
risk of sudden death by electrophysiologic testing. Isopro-
terenol, 0.5 p,g/min, was administered intravenously to one
of these two patients and accelerated the average ventricular
response from a cycle length of 420 ms to one of 289 ms
(Fig. 2) and resulted in a shortest RR interval of 200 ms
(Fig. 3). Both patients with false negative electrophysiologic
testing results (shortest RR interval of >250 ms) had a
normal cardiac investigation including coronary angiogra-
phy. Ventricular extrastimuli failed to induce ventricular
tachycardia or fibrillation.
Patients without cardiac arrest. Of the remaining 58
patients, 30 had a shortest RR interval :::;250 ms (mean 210
± 25) but no cardiac arrest (false positives) (Table I). Nine
patients had a shortest RR interval >250 to :::;280 ms (mean
269 ± 7) and 19 had a shortest RR interval >280 ms (mean
386 ± 140) (true negatives). There were no differences
between the groups in terms of accessory pathway location.
VF Non-VF
Disopyramide Infusion
Intravenous disopyramide was administered to 53 pa-
tients, including 7 who had a history of sudden death. Two
responses were observed in this group of patients: contin-
uous pre-excitation (n = 39) or sudden loss of pre-excitation
(n = 14) (Fig. 4). The mean dose of disopyramide was
140.2 ± 27 mg in patients with continuous pre-excitation
and 119 ± 35 mg in patients with sudden loss of pre-
excitation. The shortest RR interval was significantly longer
in patients with block of conduction (371 ± 163 ms) than
in patients with continuous pre-excitation (227 ± 55, p <
0.001). Similarly, the anterograde accessory pathway ef-
fective refractory period was significantly longer in patients
with block of conduction (366 ± 134 ms) than in those
with continuous pre-excitation (265 ± 27 ms, p < 0.001).
Patients with a history of sudden death (Table 1).
Among these seven patients there were two who had loss
of pre-excitation in response to disopyramide (false negative
response for risk of sudden death) (Fig. 5) and five who
had continuous pre-excitation (true positive response). In
the other patients continuous pre-excitation was seen in 25
of 27 patients with a shortest RR interval :::;250 ms, 5 of 7
with a shortest RR interval >250 and :::;280 ms and 4 of
12 with a shortest RR interval >280 ms (false positives).
The significance of the response to disopyramide was as-
sessed in terms of the sensitivity, specificity and predictive
accuracy for predicting sudden death (Table 2), and for
predicting the shortest RR interval determined during elec-
trophysiologic testing (Table 3). Continuous pre-excitation
had a sensitivity of 71.4% for predicting sudden death, but
a low specificity (26.1%) and low predictive accuracy
(12.8%). The effect of varying the shortest RR interval that
was desired to be predicted by the test result of continuous
pre-excitation was examined. The optimal combination of
30 of 58
34 of 46
30 of 50i
7 of 9
5 of 7
4 of 6*
Shortest RR interval oS250 ms
Disopyramide, continuous
pre-excitation
Exercise testing. continuous
pre-excitation
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Figure 2. Atrial fibrillation induced
in the drug-free state in the electro-
physiologylaboratoryin a patient with
a past history of ventricular fibrilla-
tion, The shortest RR interval during
atrial fibrillation was 295 ms.
Y6
. .
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a specificity of 75% and predictive accuracy of 92.3% was
observed for a shortest RR interval <290 ms.
Patients with atrial fibrillation. The response of atrial
fibrillation to disopyramide was observed in 21 patients.
The mean shortest RR interval for these patients was 210
Figure 3. Same patient as in Figure 2. Each RR interval between
consecutive pre-excited QRS complexes is measured and plotted,
Column 1 includes RR intervalsmeasuredduring atrial fibrillation
induced in the drug-free state in the electrophysiology laboratory;
the shortest RR interval was 295 ms. Column 2 includes RR
intervals during intravenous infusionof isoproterenol, 0,5 ILg/min;
the shortest RR interval was 200 ms. Column 3 was measured
after intravenous administration of disopyramide, 100 mg, with
isoproterenol discontinued; the shortest RR interval was 461 ms.
Only a small number of intervals were measured in column 3
because atrial fibrillation terminated and block of conduction in
the accessory pathway was induced.
880 0
o
± 46 ms and this was prolonged to 268 ± 102 ms (p <
0.(01) after disopyramide. However, in patients with a shortest
RR interval ~210 ms, disopyramide prolonged the interval
by 37 ± 38 ms, whereas in patients with a shortest RR
interval >210, disopyramide prolonged it by 99.4 ± 101
ms (p < 0.05). Furthermore, in seven of eight patients with
a shortest RR interval ~200 ms it remained ~250 ms after
disopyramide.
Patients with loss of pre-excitation. Seven patients with
loss of pre-excitation on the surface ECG with disopyramide
had electrophysiologic assessment before and after admin-
istration of the drug. In one of these patients, atrial pre-
mature stimuli conducted over the accessory pathway, but
with a long conduction time (Fig. 6). This long conduction
time permitted AV node conduction to predominate at the
cycle lengths of sinus rhythm leading to the apparent loss
of pre-excitation. In the remaining patients, accessory path-
way conduction could not be observed until drug effects
dissipated.
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Exercise Testing
Continuous versus sudden loss of pre-excitation. Graded
treadmill exercise was performed in 56 patients, including
6 with a history of sudden death. Three responses were
observed: I) continuous pre-excitation (n = 34), 2) gradual
loss of pre-excitation (n = 9), and 3) sudden loss of pre-
excitation (n = 13). The mean shortest RR interval for each
of these groups was 236 ± 64, 242 ± 37 and 410 ± 148
ms, respectively. An analysis of variance demonstrated sig-
nificant differences among these groups (F = 19.0 I). The
difference was between the group with sudden loss of pre-
excitation and the other two groups. Although patients with
a gradual loss of pre-excitation had a relatively short RR
interval, they were excluded from consideration in the de-
lA CC Vo!. 10. No.2
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Figure 4. Sudden loss of pre-excita-
tion after intravenous disopyramid e is
observed in the fourth QRS complex.
The surface ECG leads demonstrate ill
that pre-excitation due to a left lateral
accessory pathway is suddenly nor-
mal ized . The electrograms demon- I SECOND
strate that loss of pre-excitat ion is not RAJ
due to a change in AV node conduc- j
tion. HB = His bundle electrogram; ! I I
I
Iand RA = right atrial elect rogram. I
~ t I~ .jj~Y dlr 111 /Ifr ~
termination of sensitivity, specificity and predictive accu-
racy. This exclusion was based on the premise that a gradual
loss of pre-excitation could be due to relatively improved
conduction over the AV node or to a change in accessory
pathway characteristics (2) and thus potentially could be
observed with either a short or a long shortest RR interval.
Thus. one patient with a prior cardiac arrest and eight other
patients were excluded from subsequent consideration. Con-
tinuous pre-excitation with exercise had a sensitivity of 80%,
a specifi city of 28.6% and a predictive accuracy of 11 .8%
for detecting patients with sudden death (Table 2).
Predicting the shortest RR intervals. The results of
exercise testing were examined for predicting the duration
of the other shortest RR intervals. The best combination of
results was obtained for continuous pre-excitation with ex-
ercise predicting a shortest RR interval :::; 300 to 330 ms
(sensitivity 89%, specificity 75% and predictive accuracy
91%). Despite this usefulness of exercise testing in pre-
dieting the shortest RR interval, the cycle length during
exercise at which pre-excitation was suddenly lost (mean
446 ± 133 ms) did not correlate with the shortest RR
interval (410 ± 148 rns, r = 0.4 19)or accessory pathway
effective refractory period (458 ± 45 ms, r = 0.387). Two
patients lost pre-excitation during recovery after exercise at
heart rates lower than those achieved during peak exercise,
suggesting that factors other than rate determined loss of
pre-excitation with exercise.
A total of 22 of 67 patients had sudden loss of pre-
excitation with either disopyramide or exercise, only 3 had
a shortest RR interval :::; 250 ms and none had a shortest
RR interval :::; 200 ms.
Discussion
This study suggests that both invasive and noninvasive
tests have poor predictive accuracy for identifying patients
ai'll VI
DB 34 49 46
NSR.lJSClf!"tIlAUU 1001119 LV.
I
Figure 5. Same patient as in Figure
2. Disopyramid e , 100 mg. was ad-
ministered intravenously with term i-
nation of atrial fibrillation and loss of
pre-excitation , demonstrating that drug-
induced loss of pre-excitation can oc-
cur in a patient with a past history of
sudden death. NSR = norm al sinus
rhythm.
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Table 2. Prediction of Sudden Death by Invasive and Noninvasive Testing
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Electroph ysiologic testing (shortest
RR interval RR 5 250 ms)*
Disopyramide (continuous pre-
excitation)*
Exercise testing (continuous pre-
excitation)*
' Definition of positive test result.
Sensitivity (o/c )
77.8
71.4
80.0
Specificity (%)
48.3
26. 1
28.6
Predictive
Accuracy (%)
18.9
12.8
11.8
with Wolff-Parkinson-White syndrome who are at risk for
sudden death. One reason for this is suggestedby Bayesian
analysis (14) and relates to the relatively low incidence of
sudden death in patients with Wolff-Parkinson-White syn-
drome. Another is that, although many patients in our study
(37 of 67) were capable of sustaining rapid ventricular rates
in atrial fibrillation , not all patients will have atrial fibril-
lation (24 of 67 in this study) and, thus, only a portion of
the patients are exposed to the risk of sudden death. Of
those exposed to atrial fibrillation, the majority presumably
either received early treatment or have ventricles that are
electrically stable and capable of sustaining rapid rates with-
out the imminent development of ventricular fibrillation .
Early treatmentwould be expected to be important , because
patients with a history of prior atrial fibrillation had a short
shortest RR interval (mean 209 ± 51 ms) during atrial
fibrillation, whereas patients with only a history of recip-
rocating tachycardiahad relativelyslow ventricularresponse
rates during induced atrial fibrillation (mean shortest RR
interval 295 ± 113 ms, p < 0.005). Thus, medical inter-
vention may have favorably altered the outcome in these
patients, but as a result reduced the predictive value of the
testing.
Predictive value of electrophysiologic testing. Con-
sistent with the study of Klein et al. (9), which suggested
that the shortest RR interval between consecutive pre-ex-
cited beats (shortest RR interval) was a better predictor of
sudden death than was the anterograde accessory pathway
effective refractory period, we observed a short "mean
shortest" RR interval in the patients with sudden death.
Although accessory pathway effective refractory period tends
to correlate with the shortest RR interval (15), the accessory
pathwayrefractoriness cannotalways be measuredand other
factors such as rate may also affect refractoriness (15- 17).
Therefore, we analyzed the sensitivity, specificity and pre-
dictive accuracy of a shortest RR interval ':::;250 ms for
identifying patients with sudden cardiac death. The sensi-
tivity of electrophysiologic testing (77.8%) in identifying
patients withsudden death was lower than expected because
of the presence of two patients who had a long shortest RR
interval. The sensitivity increases to 87.5% if one patient
is excluded because amiodarone therapy was discontinued
only 2 months before electrophysiologic testing. The sen-
sitivity is lowerusing the morestringent criteria of a shortest
RR interval :::;200 ms, because an additional two patients
with sudden death had a shortest RR interval >200 ms but
not exceeding 250 ms. A previous report (9) would suggest
that it is rare to see slow ventricular responses to atrial
fibrillation in patientswith sudden death, and thus our study
likely underestimates the sensitivity.
Table 3. Prediction of Shortest RR Interval of Pre-excited Beats in Atrial Fibrillation by
Noninvasive Tests
Predictive
Sensitivity (%) Specificity (%) Accuracy (%)
Shortest RR interval 5 250 ms
Disopyramide 90.6 52.3 74.3
Exercise jOO.O 54. 1 67.6
Disopyramide + exercise * 91.2 66.7 75.6
Shortest RR interval :s290 ms
Disopyramide 87.8 75.0 92.3
Exercise 90.9 71.4 88.2
Disopyramide + exercise' 83.3 87.5 95.2
Shortest RR interval :s 300 ms
Disopyram ide 83.7 70.0 92.3
Exercise 88.0 75.0 9 1.2
*Positive result = continuous pre-excitation on both tests.
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Figure 6. A patient with a postero-
septal accessory pathway with mani-
fest pre-excitation hadapparent loss of
pre-excitation after disopyramide , re-
vealing an intraventricular conduction
disturbance seen in the surface ECG
leads (5 " S2). Proximal (CSp) and dis-
tal (CSD) coronary sinus electrograms
during right atrial (RA) refractory pe-
riod determination reveal that the ac-
cessory pathway is capable of con-
duction witha long AV intervalof 190
ms measured at the proximal coronary
sinus. The pre-excited complex is in-
dicated with a star. HB = Hisbundle
electrogram; RV = right ventricular.
We identified the potential reasons fo r this failure of the
shortest RR interval :::;250 ms to predict sudden death . One
patient had his last episode of ventricular fibrillation 19 years
before electrophysiologic testing and the accessory pathway
properties may have changed over this period. This patient
had been previously treated with amiodarone and, despite
a washout period of 2 months, there may have been residual
drug effects. A second patient with a history of ventricular
fibrillation had a shortest RR interval of 295 ms in the drug-
free state. This shortened to 200 ms with a relatively small
infusion of isoproterenol, suggesting that beta-adrenoceptor
stimulation, or rapid rates of conduction, or both, were
necessary to enhance conduction through the accessory path-
way. This is consistent with the data of previous investi-
gators (18,19) who showed that in three of five patients with
a control shortest RR interval :::;250 ms, isoproterenol, 4
ILg/m in , lowered it to ~200 ms. We did not administer
isoproterenol to all patients during induced atrial fibrillation.
Although this may have increased the sensitivity of elec-
trophysiologic testing, it may have lowered an already poor
specificity.
The low specificity and predictive accuracy suggest that
electrophysiologic testing has severe limitations as a screen-
ing procedure to detect patients at risk for sudden death.
but may be useful in identifying patients not at risk from
sudden death due to atrial fibrillation. We considered the
use of noninvasive techniques to screen patients before elec-
trophysiologic testing . If continuous pre-excitation on ex-
ercise and disopyramide testing had been used as criteria
for referral for electrophysiologic testing, then two of nine
patients with a history of sudden death would have been
excluded. Electrophysiologic testing would then have fur-
ther assigned one patient with sudden death to a low risk
group (total three of nine), suggesting a limited value to
this approach.
Disopyramide testing. Several studies have demon-
strated that block of conduction in accessory pathways after
administration of an antiarrhythmic drug such as ajmaline
(3) or procainamide (4) predicts a long accessory pathway
effective refractory period. Continuous pre-excitation after
intravenous administration of disopyramide , :::;2 mg/kg, had
a sensitivity of 71.4 % for detecting patients with a history
of sudden death. In contrast , the specificity and predictive
accuracy of this response were very low and comparable
with those of exercise testing. Thus, loss of pre-excitation
suggests that the patient is not at high risk for rapid atrial
fibrillation, although continuous pre-excitation is poor at
specifi cally identifying the patient at risk for sudden death .
Loss of pre-excitation occurred over one cycle. We did
not observe, as others have (2), any instances of transient
2: I conduction over the accessory pathway in this group of
patients. This would have been expected if the agent acted
solely through prolongation of refractoriness . A potential
explanation for this is repetitive concealed conduction in
the accessory pathway after the initial blocked cycle . re-
sulting in continuous refractoriness on subsequent cycles
(20).
In one patient, apparent loss of pre-excitation was due
not to block of conduction in the accessory pathway but
rather to slowing of conduction velocity, permitting acti-
vation of the ventricles to occur by way of the AV node
during spontaneous sinus rhythm. The recent demonstration
(21) by direct recording that decremental accessory pathway
conduction occurs is consistent with the view that disopyr-
amide acts directly on the accessory pathway to slow con-
duction. In this instance , slowing of conduction is due to a
mechanism other than calcium channel blockade.
The slowirig of the ventricular response in atrial fibril-
lation after disopryramide is consistent with the data of Kerr
et al. (22). However, the observation that the drug is least
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effective in patients with a very short RR interval is of
concern because these patients are in greatest need of an
effective drug to prevent rapid atrial fibrillation.
Exercise testing. Exercise testing has been advocated
as a method for detecting patients not at risk for sudden
death (1,2). However, in our study, one patient with a
history of sudden death had a sudden loss of pre-excitation
and, as a result, sensitivity was only 80% for assessing risk
of sudden death. Potential responses to exercise include
increased or new pre-excitation, continuous pre-excitation,
sudden or gradual complete loss of pre-excitation, partial
loss of pre-excitation and 2: I block over the accessory path-
way (23,24). In our study, all patients had manifest pre-
excitation and we could only observe changes in this pattern.
We categorized our patients as those exhibiting continuous
pre-excitation or gradual complete loss or sudden loss of
pre-excitation. Patients with sudden loss of pre-excitation,
consistent with previous studies (l ,2,5,6), had a long short-
est RR interval. Surprisingly, there was no correlation be-
tween the cycle length at which block in the accessory
pathway occurred during exercise and the shortest RR in-
terval or accessory pathway effective refractory period, sug-
gesting that factors other than cycle length were involved
in the mechanism of exercise-induced block (25). The max-
imal specificity and predictive accuracy for predicting ven-
tricular rates during atrial fibrillation occurred for a shortest
RR interval :5290 ms for disopyramide and :5300 to 330
ms for exercise testing, suggesting that disopyramide is
more potent than exercise testing in producing accessory
pathway block. Furthermore, 5 of14 patients who had block
of conduction by disopyramide did not have block of con-
duction with exercise, whereas only I patient who had block
of conduction with exercise failed to have it with disopyr-
amide.
Limitations of study. This study cannot address the
issue of how many patients with rapid atrial fibrillation in
the electrophysiology laboratory will ultimately undergo
sudden death because it would be unethical to carry out a
natural history study of the severely symptomatic patient.
However, 37 (55%) of 67 patients had a shortest RR interval
:5250 ms, and it is highly unlikely that many of them would
later experience sudden death in the absence of therapy,
historical data suggest a sudden death mortality rate of only
0(26) to 4% (27). Furthermore, because patient awareness
may lead to early therapy, the natural history of the syn-
drome may be favorably altered.
A further problem in the application of these data to
determining the usefulness of these tests for screening pa-
tients at risk for sudden death in the general population is
that our patients were highly selected, had an incidence of
sudden death of 13.4%, and 55% of them had a shortest
RR interval :::::250 ms. In contrast, in a group of asymp-
tomatic patients, only 17% had a shortest RR interval :::::250
ms (28); despite this 17% incidence rate of rapid atrial
fibrillation, none of the patients had sudden death during a
29 month follow-up period without therapy. Thus, the spec-
ificity of the tests for identifying patients who will have
sudden death may be even lower in the asymptomatic group
of patients.
Conclusions. Our data suggest that although both elec-
trophysiologic and noninvasive testing have a good sensi-
tivity, they fail to identify all patients with a history of
sudden death. The major limitation to the use of these tests
in screening for patients with Wolff-Parkinson-White syn-
drome at risk for sudden death is their low specificity and
predictive accuracy. However, they may be useful in iden-
tifying patients at low risk for the development of ventricular
fibrillation.
We thank William DeYoung, BSc. for assistance in statistical analysis and
we are grateful to Daphne Vigna for preparation of the manuscript.
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